Merck (NYSE: MRK) referred to as MSD outside U.S. and Canada, and Ridgeback Biotherapeutics last Friday made it known that Molnupiravir...

Exscientia plc, an Artificial Intelligence firm focused on discovering, designing and developing the highest quality medications in the...

2021 has already witnessed many eventful FDA approvals. Not even the pandemic could stop biopharma’s historic ability to push prospects...

Osaka-based pharma, Takeda Pharmaceutical Company Limited (“Takeda”) on Wednesday announced the U.S. Food and Drug Administration (FDA)’s...

Life sciences venture firm TP on Wednesday announced the launch of Replicate Bioscience in a bid to replicating the success RNA...

The trial of the founder of Theranos, Elizabeth Holmes began on Wednesday in federal court in San Jose, California. Elizabeth who dropped...

California-based RenovoRx, Inc. (NASDAQ: RNXT) has filed for offering up to 1.85 million units of securities in an initial public...

On August 6, 2021, the U.S. Food and Drug Administration announced it has approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous...

Amgen and Teneobio on July 27, 2021 announced they had reached an agreement which will see Amgen acquire Teneobio, a privately held,...

The U.S. securities regulator in an exclusive report released on July 30 says it will not allow Chinese companies to undertake...

Is there ample proof that Biogen’s new Alzheimer’s med Aduhelm is beneficial to patients, physicians and society beyond the existing...

European Medicines Agency grants Orphan Drug Designation to Saroglitazar Mg for the treatment of patients with Primary Biliary...

Understanding there’s nothing small about a small cell lung cancer diagnosis, Jazz Pharmaceuticals is collaborating with four major lung...

Have you ever imagined the possibility of using your smartphone with your brain? Like, being able to operate your device with your mind,...

Biogen’s decision to price its historic Alzheimer’s med Aduhelm at a mouthwatering $56,000 per year expectedly vexed lawmakers in...

With obesity prevalent, undertreated, and hugely misunderstood, Novo Nordisk has been attempting to revolutionize the field with...

The U.S. Food and Drug Administration on May 28, 2021 approved Lumakras (Sotorasib) as the first therapy for adult patients with...

Eli Lilly’s Covid-19 antibody bamlanivimab already lost its solo FDA authorization as viral variants emerged. Now, the company’s...

Americans appreciate their vaccine makers. Cases in point? Moderna and Pfizer leapfrogged into the top 10 favorite companies in the U.S....

While the worldwide sales rankings of Big Pharma’s blockbuster drugs typically feature the biggest names in the industry, new meds...